title: [THE MODERN PROSPECT FOR CITRATE MIXTURES IN THE TREATMENT OF UROLITHIASIS].
abstract: The authors present a review of literature on the use of litholytic citrate medications for conservative management of urolithiasis. Urate urolithiasis is the most common clinical condition encountered by urologists. Citrate agents, in particular Blemaren, not only may be employed in a conservative therapy of uric acid stones, but can also be successfully used in the treatment of the calcium urolithiasis, i.e. mixed composition stones, which is supported by current international urology guidelines.
authors.forename: A K
authors.initials: AK
authors.lastname: Chepurov
authors.forename: E A
authors.initials: EA
authors.lastname: Pronkin
authors.forename: A D
authors.initials: AD
authors.lastname: Bolotov
mesh_terms: D002951:Citrates / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006863:Hydrogen-Ion Concentration; D014527:Uric Acid / Q000097:blood; D014556:Urine / Q000737:chemistry; D052878:Urolithiasis / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D064804:Urological Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D002951:Citrates; D064804:Urological Agents; D014527:Uric Acid